Rankings
▼
Calendar
BSX FY 2017 Earnings — Boston Scientific Corporation Revenue & Financial Results | Market Cap Arena
BSX
Boston Scientific Corporation
$103B
FY 2017 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$9.0B
+7.9% YoY
Gross Profit
$5.9B
64.9% margin
Operating Income
$1.5B
16.9% margin
Net Income
$104M
1.1% margin
EPS (Diluted)
$0.07
Cash Flow
Operating Cash Flow
$1.4B
Free Cash Flow
$1.1B
Stock-Based Comp.
$127M
Balance Sheet
Total Assets
$19.0B
Total Liabilities
$12.0B
Stockholders' Equity
$7.0B
Cash & Equivalents
$188M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$9.0B
$8.4B
+7.9%
Gross Profit
$5.9B
$5.3B
+9.9%
Operating Income
$1.5B
$1.2B
+23.4%
Net Income
$104M
$347M
-70.0%
← Q4 2016
All Quarters
Q1 2017 →